American Association for Cancer Research

AACR Press Releases

AACR to Host Teleconference on Metastasis


October 7, 2009

Bookmark and Share

PHILADELPHIA - Approximately 90 percent of all cancer deaths are due to metastasis, which occurs when cancer cells shed from the primary tumor and develop secondary, sometimes microscopic, tumors in the body's distant organs. Although medicine has made significant strides against the more than 200 diseases collectively known as cancer, metastasis continues to present a daunting challenge.

The American Association for Cancer Research is at the forefront of efforts to control metastasis and hosted a scientific press conference on this topic for media professionals on Oct. 8, 2009, from 12:30 to 1:30 p.m. ET. The event took place at the Frontiers in Basic Cancer Research Meeting in the Stuart Room of the Boston Park Plaza Hotel.

The following world-renowned scientists spoke on the biological process of metastasis, recent scientific research and the challenges that lie ahead.

Tyler Jacks, Ph.D.
Director of the Koch Institute for Integrative Cancer Research at MIT
President of the American Association for Cancer Research


Joan Massagué, Ph.D.
Program Chairperson, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center
Member of the Institute of Medicine

Robert Weinberg, Ph.D.
Professor of Biology at MIT
Author of The Biology of Cancer

Listen to the teleconference:

Download* the mp3 of the press briefing (11.8 MB, 51 minutes and 59 seconds)

# # #

The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the world's oldest and largest professional organization dedicated to advancing cancer research. The membership includes 30,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and nearly 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowship and career development awards. The AACR Annual Meeting attracts more than 16,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. The AACR publishes six major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; and Cancer Prevention Research. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists. CR provides a forum for sharing essential, evidence-based information and perspectives on progress in cancer research, survivorship and advocacy.

Media Contact:
Jeremy Moore
(267) 646-0557
jeremy.moore@aacr.org
In Boston, October 8-11:
(617) 457-2444